ClinicalTrials.gov
public full text
Public Domain
A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Brief Description: This study is designed to evaluate the safety and tolerability of oral Selatinib Ditosilate Tablets, and explore the maximum tolerated dose (MTD) and dose-limiting toxicity in patients with advanced breast cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors#845405
- Doxil and Gemcitabine in Recurrent Ovarian Cancer#1124506
- Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies#907303
- A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin#863721
- Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer#894064
Record · ID 1045857
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive